SCHEMBL29832661

SCHEMBL29832661

CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](NC(c2ccccc2)(c2ccccc2)c2ccccc2)[C@@H](CO)O[C@H]1n1cnc2c(NC(=O)c3ccccc3)ncnc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT6 Q96LA8 1/20 0.47
▸ ADORA1 P30542 3/20 0.46
▸ P2RY12 Q9H244 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ LMNA P02545 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPY2R P49146 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SLC29A1 Q99808 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19128455 1.00 PRMT6 (0.47) PRMT6ADORA1P2RY12ADORA3ADORA2A
SCHEMBL19128567 0.90 PRMT6 (0.47) PRMT6ADORA1P2RY12ADORA3ADORA2A
SCHEMBL19927093 0.90 PRMT6 (0.47) PRMT6ADORA1P2RY12ADORA2AADORA2B
SCHEMBL19128004 0.90 PRMT6 (0.43) PRMT6P2RY12
SCHEMBL30446733 0.89 PRMT6 (0.51) PRMT6ADORA1P2RY12ADORA3ADORA2A
SCHEMBL8937133 0.89 PRMT6 (0.51) PRMT6ADORA1P2RY12ADORA3ADORA2A
SCHEMBL7032101 0.89 PRMT6 (0.51) PRMT6ADORA1P2RY12ADORA3ADORA2A
SCHEMBL30012599 0.88 P2RY12 (0.40) PRMT6ADORA1P2RY12
SCHEMBL6402239 0.88 ADORA1 (0.54) ADORA1ADORA3ADORA2AADORA2BLMNA
SCHEMBL6402244 0.88 ADORA1 (0.54) ADORA1ADORA3ADORA2AADORA2BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3402801-B1 CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER INNATE TUMOR IMMUNITY INC (US) 2025-08-06 — — EP disclosed
CN-109451740-B Cyclic dinucleotides for the treatment of disorders associated with STING activity, such as cancer 先天肿瘤免疫公司 2022-09-02 — — CN disclosed
Send feedback